All In Biotech

Drug Trial Radar · NCT06172296

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 478 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

478

Planned (sponsor's estimate)

Start

Apr 19, 2024

Primary completion

Dec 31, 2029

Study completion Dec 31, 2029

Sponsor

Sponsor type
NIH
First posted
Dec 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neuroblastoma cells, but is not present on many healthy or normal cells in the body. When dinutuximab binds to the neuroblastoma cells, it helps signal the immune system to kill the tumor cells. This helps the cells of the immune system kill the cancer cells, this is a type of immunotherapy. When chemotherapy and immunotherapy are given together, during the same treatment cycle, it is called chemoimmunotherapy. This clinical trial randomly assigns patients to receive either standard chemotherapy and surgery or chemoimmunotherapy (chemotherapy plus dinutuximab) and surgery during Induction therapy. Chemotherapy drugs administered during Induction include, cyclophosphamide, topotecan, cisplatin, etoposide, vincristine, and doxorubicin. These drugs work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing or by stopping them from spreading. Upon completion of 5 cycles of Induction therapy, a disease evaluation is completed to determine how well the treatment worked. If the tumor responds to therapy, patients receive a tandem transplantation with stem cell rescue. If the tumor has little improvement or worsens, patients receive chemoimmunotherapy on Extended Induction. During Extended Induction, dinutuximab is given with irinotecan, temozolomide. Patients with a good response to therapy move on to Consolidation therapy, when very high doses of chemotherapy are given at two separate points to kill any remaining cancer cells. Following, transplant, radiation therapy is given to the site where the cancer originated (primary site) and to any other areas that are still active at the end of Induction. The final stage of therapy is Post-Consolidation. During Post-Consolidation, dinutuximab is given with isotretinoin, with the goal of maintaining the response achieved with the previous therapy. Adding dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy may be better at treating children with newly diagnosed high-risk neuroblastoma.

Conditions

  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma

Interventions

  • Biospecimen CollectionProcedure

    Undergo blood and urine sample collection

  • Bone Marrow AspirationProcedure

    Undergo bone marrow aspiration

  • Bone Marrow BiopsyProcedure

    Undergo bone marrow biopsy

  • CarboplatinDrug

    Given IV

  • CisplatinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT scan

  • CyclophosphamideDrug

    Given IV

  • DinutuximabBiological

    Given IV

  • DoxorubicinDrug

    Given IV

  • Echocardiography TestProcedure

    Undergo ECHO

  • EtoposideDrug

    Given IV

  • FDG-Positron Emission Tomography and Computed Tomography ScanProcedure

    Undergo FDG PET

  • Hematopoietic Cell TransplantationProcedure

    Undergo stem cell infusion

  • IrinotecanDrug

    Given IV

  • IsotretinoinDrug

    Given PO

  • LeukapheresisProcedure

    Undergo apheresis

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • MelphalanDrug

    Given IV

  • Multigated Acquisition ScanProcedure

    Undergo MUGA

  • Radiation TherapyRadiation

    Undergo radiation therapy

  • Radionuclide ImagingProcedure

    Undergo I-MIBG scan

  • Survey AdministrationOther

    Ancillary studies

  • TemozolomideDrug

    Given PO or via NG or G tube

  • ThiotepaDrug

    Given IV

  • TopotecanDrug

    Given IV

  • Tumor ResectionProcedure

    Undergo tumor resection surgery

  • VincristineDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event free survival (EFS)Time frame: Up to 3 years

Locations

180 sites in 5 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama · Recruiting

  • USA Health Strada Patient Care Center

    Mobile, Alabama · Recruiting

  • Banner Children's at Desert

    Mesa, Arizona · Recruiting

  • Phoenix Childrens Hospital

    Phoenix, Arizona · Recruiting

  • Banner University Medical Center - Tucson

    Tucson, Arizona · Recruiting

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Kaiser Permanente Downey Medical Center

    Downey, California · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • Loma Linda University Medical Center

    Loma Linda, California · Recruiting

  • Miller Children's and Women's Hospital Long Beach

    Long Beach, California · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Mattel Children's Hospital UCLA

    Los Angeles, California · Recruiting

  • Valley Children's Hospital

    Madera, California · Recruiting

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California · Recruiting

  • Sutter Medical Center Sacramento

    Sacramento, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Rady Children's Hospital - San Diego

    San Diego, California · Recruiting

  • UCSF Medical Center-Mission Bay

    San Francisco, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Connecticut Children's Medical Center

    Hartford, Connecticut · Recruiting

  • Yale University

    New Haven, Connecticut · Recruiting

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware · Recruiting

  • Children's National Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Broward Health Medical Center

    Fort Lauderdale, Florida · Recruiting

  • Golisano Children's Hospital of Southwest Florida

    Fort Myers, Florida · Recruiting

  • UF Health Cancer Institute - Gainesville

    Gainesville, Florida · Recruiting

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida · Recruiting

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida · Recruiting

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida · Recruiting

  • Nicklaus Children's Hospital

    Miami, Florida · Recruiting

  • AdventHealth Orlando

    Orlando, Florida · Recruiting

  • Arnold Palmer Hospital for Children

    Orlando, Florida · Recruiting

  • Nemours Children's Hospital

    Orlando, Florida · Recruiting

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida · Recruiting

  • Saint Mary's Medical Center

    West Palm Beach, Florida · Recruiting

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital

    Atlanta, Georgia · Recruiting

Showing 40 of 180 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.